Post-earnings recap
Reported
Wed, Feb 23, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
13%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bausch Health's earnings report shows a significant miss on EPS, which likely contributed to the 2.96% decline in stock price. Investors may be concerned about the company's financial performance and lack of guidance. The absence of revenue figures further complicates the outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.19 | N/A | -82.41% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.